Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3891494019 | Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3891495018 | Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 56934801000001112 | Conjugated oestrogens 625microgram tablets and Norgestrel 150microgram tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Estrogen-progestin preparation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Progesterone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Estrogen | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Synthetic progestogen | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing conjugated estrogen | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing norgestrel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Conjugated estrogen | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Norgestrel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Norgestrel | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Norgestrel | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Conjugated estrogen | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Conjugated estrogen | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 625 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 0.15 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 0.625 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Norgestrel | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Conjugated estrogen | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing conjugated estrogen and norgestrel in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only conjugated estrogen and norgestrel in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Conjugated estrogen | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Norgestrel | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Conjugated estrogen | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Norgestrel | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Conjugated estrogen | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Not applicable dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Route of administration not applicable | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) combination product indicator | Combination product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Norgestrel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Dose form not applicable (qualifier value) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Dose form not applicable (qualifier value) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has dispensed dose form | Dose form not applicable (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Dose form not applicable (qualifier value) | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Prempak-C 0.625mg tablets (Wyeth Laboratories) | Is a | True | Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Prempak-C 0.625mg tablets (PI) (Waymade Ltd) | Is a | True | Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Conjugated oestrogens 625microgram tablets and Norgestrel 150microgram tablets 120 tablet | Is pack of | False | Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Prempak-C 0.625mg tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Conjugated oestrogens 625microgram tablets and Norgestrel 150microgram tablets 120 tablet | Has VMP | True | Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR